JX06 is a potent, selective and covalent inhibitor of PDK. JX06 inhibits PDK1, PDK2 and PDK3 with IC50s of 49 nM, 101 nM, and 313 nM, respectively. JX06 inhibits PDK1 activity via covalently binding to a cysteine residue in an irreversible manner. JX06 shows significant antitumor activity[1].
JX06 barely shows inhibitory activity against PDK4 at a concentration of 10 μM[1]. JX06 (1-10 μM; 48 hours) induces cell apoptosis in cancer cells with high ECAR/OCR[1]. JX06 (0-0.6 μM; 72 hours) dose-dependently suppresses the growth of A549 cells[1]. JX06 (0.1-10 μM; 6-24 hours) inhibits PDHA1 phosphorylation in A549 cells in a time- and dose-dependent manner[1]. JX06 (1-10 μM) increases glucose uptake and intracellular ATP level and reduces aerobic glycolysis determined by the lactate production in A549 cells[1]. JX06 (1-10 μM; 24 hours) induces ROS generation in cancer cells with high extracellular acidification rate (ECAR)/ oxygen consumption rate (OCR) [1].
上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
Apoptosis Analysis[1]
Cell Line:
A549, EBC-1, HT-29 and H460 cells
Concentration:
0, 1, 3, 10 μM
Incubation Time:
48 hours
Result:
Induces cell apoptosis in A549 and EBC-1 cells.
Cell Viability Assay[1]
Cell Line:
A549 cells
Concentration:
0, 0.2, 0.4, 0.6 μM
Incubation Time:
72 hours
Result:
Inhibits the viability of A549 cells in a dose dependent manner.
Western Blot Analysis[1]
Cell Line:
A549 cells
Concentration:
0, 0.1, 0.3, 1, 3, 10 μM
Incubation Time:
0, 6, 12, 24 hours
Result:
Decreased PDHA1 phosphorylation at both serine 293 and serine 232 (S293 and S232) in a time- and dose-dependent manner.
体内研究 (In Vivo)
JX06 (40-80 mg/kg; i.p. for 21 days) inhibits tumor growth in vivo[1].
上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model:
A549 subcutaneous xenograft mice[1]
Dosage:
40, 80 mg/kg
Administration:
I.p. injections for 21 days
Result:
Reduced tumor weights and 67.5% tumor volume at the dose of 80 mg/kg compared with the vehicle control. Well tolerated at the administration dose.
分子量
324.51
Formula
C10H16N2O2S4
CAS 号
729-46-4
运输条件
Room temperature in continental US; may vary elsewhere.
[1]. Wenyi S, et, al. JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification. Cancer Res. 2015 Nov 15; 75(22): 4923-36.